Week 6 drugs Flashcards
Methotrexate
anti-neoplastic and anti-RA
blocks DHFR – inhibits folate metabolism
Hydroxychloroquine
anti-RA
prevents acidification of macrophage cytosol; also blocks TLR-9 in DC which prevents IL and TNF release
Leflunomide
anti-RA
inhibits pyrimidine synthesis by blocking the orotate pathway; affects DNA/RNA synthesis in T cells
Sulfasalazine
anti-RA
alternative to Mtx; inhibits COX and scavenges free radicals
Gold
anti-RA
reduces macrophage phagocytosis and affects APCs/T cells
Cyclosporine
anti-RA
inhibits calcineurin, which inhibits T cells activation
Etanercept and Inflixumab
anti-RA
block TNF action; Entanercept is a fake receptor coupled to TNF ab and Inflixumab is just a TNF ab
Ankinra
anti-RA – not commonly used
IL-1 receptor antagonist
Abatacept
anti-RA
binds CD80 on T cells to prevent APC activation of T cells
Rituximab
anti-RA
binds CD20 which targets B cells for destruction, results in decreased Ab production
ifosfamide
anti-neoplastic
alkylating agent that cross links DNA, converted to phosphoramide mustard in the liver; cell cycle non-specific
etoposide
anti-neoplastic
blocks Topo II causing strand breaks; works in S and G2
busulfan
anti-neoplastic
alkylating agent that cross links DNA, given prior to transplant; cell cycle non-specific
fludarabine
anti-neoplastic
decreases DNA synthesis by interfering with dATP (purine blocker)
Ara-C
anti-neoplastic
decreases DNA synthesis by interfering with dCTP (pyrimidine blocker)